Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
A recent study by researchers at Leiden University suggests that daily probiotic intake can alleviate negative emotions such as anxiety, stress, and fatigue. The study, conducted by Dr. Katerina Johnson and Dr. Laura Steenbergen, involved young, healthy adults who consumed probiotics containing Lactobacillus and Bifidobacterium strains for a month. Participants reported improved moods after approximately two weeks, as measured by daily mood assessments.
Unlike traditional antidepressants, which often dampen both negative and positive emotions, the probiotics appeared to specifically reduce negative feelings without affecting positive ones. Additionally, individuals with traits like risk avoidance experienced more pronounced mood improvements. The study also noted slight enhancements in participants’ ability to recognize facial expressions, indicating potential benefits in emotional processing.
While these findings are promising, the researchers caution that probiotics should not replace antidepressants. However, they may serve as a supplementary approach to mental well-being. The study emphasizes the importance of simple daily mood tracking in psychological research, as it proved more sensitive to changes than standard questionnaires.
For more details, visit the Leiden University news article.
The Netherlands will host the NATO Summit on 24-25 June 2025 at the World Forum in The Hague, leading to significant traffic disruptions and security measures across the Randstad region from 22-26 June. Motorists can expect road closures on major routes, while public transport services will be adjusted, with certain trams and buses suspended, and travelers are advised to avoid the area or use alternative transportation options.
This summer, students and professionals passionate about pharmaceutical innovation have a unique opportunity to gain hands-on experience in modern drug development. The...
Leiden University researchers have developed the first-ever ‘dengue-on-a-chip’ model, using organ-on-a-chip technology to simulate the human body’s response to dengue infection, particularly focusing on hemorrhagic shock. This innovative tool offers a more ethical and cost-effective alternative to animal testing, aiding in the study of disease progression and the development of targeted treatments for the growing global health threat posed by dengue.